<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-27T12:39:21Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/92459" metadataPrefix="mods">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/92459</identifier><datestamp>2025-03-18T14:23:40Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>López Gómez, Ana</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Peláez Prestel, Héctor Fernando</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Juárez Martín-Delgado, Ignacio</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2024-01-11T10:19:50Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2024-01-11T10:19:50Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2023-10</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="citation">Lopez-Gomez A, Pelaez-Prestel HF, Juarez I. Approaches to evaluate the specific immune responses to SARS-CoV-2. Vaccine. 2023 Oct 13;41(43):6434-6443. doi: 10.1016/j.vaccine.2023.09.033</mods:identifier>
   <mods:identifier type="issn">0264-410X</mods:identifier>
   <mods:identifier type="doi">10.1016/j.vaccine.2023.09.033</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/20.500.14352/92459</mods:identifier>
   <mods:identifier type="officialurl">https://www.sciencedirect.com/science/article/pii/S0264410X23011039?via%3Dihub</mods:identifier>
   <mods:identifier type="relatedurl">https://pubmed.ncbi.nlm.nih.gov/37770298/</mods:identifier>
   <mods:abstract>The SARS-CoV-2 pandemic has a huge impact on public health and global economy, meaning an enormous scientific, political, and social challenge. Studying how infection or vaccination triggers both cellular and humoral responses is essential to know the grade and length of protection generated in the population. Nowadays, scientists and authorities around the world are increasingly concerned about the arrival of new variants, which have a greater spread, due to the high mutation rate of this virus. The aim of this review is to summarize the different techniques available for the study of the immune responses after exposure or vaccination against SARS-CoV-2, showing their advantages and limitations, and proposing suitable combinations of different techniques to achieve extensive information in these studies. We wish that the information provided here will helps other scientists in their studies of the immune response against SARS-CoV-2 after vaccination with new vaccine candidates or infection with upcoming variants.</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">Attribution 4.0 International</mods:accessCondition>
   <mods:titleInfo>
      <mods:title>Approaches to evaluate the specific immune responses to SARS-CoV-2</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>